Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 55 | 140 | 165 |
| Gross Profit | N/A | N/A | 55 | 140 | 165 |
| Operating Expenses | 18,711 | 20,351 | 22,308 | 17,917 | 13,991 |
| Operating Income | -18,711 | -20,351 | -22,253 | -17,777 | -13,826 |
| Other Income | -589 | 476 | 65 | 279 | -60 |
| Pre-tax Income | -19,300 | -19,874 | -22,188 | -17,498 | -13,887 |
| Income Tax | 861 | 537 | 79 | 93 | 4 |
| Net Income Continuous | -20,161 | -20,411 | -22,268 | -17,591 | -13,891 |
| Net Income | $-20,161 | $-20,411 | $-22,268 | $-17,591 | $-13,891 |
| EPS Basic Total Ops | -0.61 | -0.89 | -1.71 | -1.48 | -1.37 |
| EPS Basic Continuous Ops | -0.61 | -0.89 | -1.71 | -1.48 | -1.37 |
| EPS Diluted Total Ops | -0.61 | -0.89 | -1.71 | -1.48 | -1.37 |
| EPS Diluted Continuous Ops | -0.61 | -0.89 | -1.71 | -1.48 | -1.37 |
| EPS Diluted Before Non-Recurring Items | -0.61 | -0.89 | -1.71 | -1.48 | -1.37 |
| EBITDA(a) | $-18,617 | $-20,267 | $-22,170 | $-17,713 | $-13,811 |